CY2019A - The use of bmy 14802 in the treatment of anxiety in benzodiazepine-withdrawn patients - Google Patents

The use of bmy 14802 in the treatment of anxiety in benzodiazepine-withdrawn patients

Info

Publication number
CY2019A
CY2019A CY201998A CY201998A CY2019A CY 2019 A CY2019 A CY 2019A CY 201998 A CY201998 A CY 201998A CY 201998 A CY201998 A CY 201998A CY 2019 A CY2019 A CY 2019A
Authority
CY
Cyprus
Prior art keywords
treatment
bmy
benzodiazepine
anxiety
withdrawn
Prior art date
Application number
CY201998A
Other languages
English (en)
Original Assignee
Bristol Myers Squibb Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bristol Myers Squibb Co filed Critical Bristol Myers Squibb Co
Publication of CY2019A publication Critical patent/CY2019A/xx

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/20Hypnotics; Sedatives
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/22Anxiolytics

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Neurosurgery (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Anesthesiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
CY201998A 1991-10-24 1998-02-20 The use of bmy 14802 in the treatment of anxiety in benzodiazepine-withdrawn patients CY2019A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US78201091A 1991-10-24 1991-10-24

Publications (1)

Publication Number Publication Date
CY2019A true CY2019A (en) 1998-02-20

Family

ID=25124656

Family Applications (1)

Application Number Title Priority Date Filing Date
CY201998A CY2019A (en) 1991-10-24 1998-02-20 The use of bmy 14802 in the treatment of anxiety in benzodiazepine-withdrawn patients

Country Status (18)

Country Link
US (1) US5278164A (sh)
EP (1) EP0538897B1 (sh)
JP (1) JPH05238934A (sh)
KR (1) KR100196334B1 (sh)
AT (1) ATE150645T1 (sh)
AU (1) AU649169B2 (sh)
CA (1) CA2081062A1 (sh)
CY (1) CY2019A (sh)
DE (1) DE69218544T2 (sh)
DK (1) DK0538897T3 (sh)
ES (1) ES2101000T3 (sh)
GR (1) GR3022945T3 (sh)
HK (1) HK113897A (sh)
IL (1) IL103499A0 (sh)
OA (1) OA09766A (sh)
PH (1) PH30028A (sh)
TW (1) TW217382B (sh)
ZA (1) ZA928105B (sh)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2011091418A1 (en) * 2010-01-25 2011-07-28 Northeastern University Screening method for adverse side effects of a therapeutic pharmaceutical drug

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4605655A (en) * 1984-03-06 1986-08-12 Bristol-Myers Company Antipsychotic 1-fluorophenylbutyl-4-(2-pyrimidinyl)piperazine derivatives
US5055470A (en) * 1989-06-01 1991-10-08 Bristol-Myers Squibb Co. Method of treatment of ischemia in brain

Also Published As

Publication number Publication date
GR3022945T3 (en) 1997-06-30
TW217382B (sh) 1993-12-11
ATE150645T1 (de) 1997-04-15
OA09766A (en) 1993-11-30
EP0538897B1 (en) 1997-03-26
KR930007452A (ko) 1993-05-20
CA2081062A1 (en) 1993-04-25
ES2101000T3 (es) 1997-07-01
IL103499A0 (en) 1993-03-15
AU2716592A (en) 1993-04-29
KR100196334B1 (ko) 1999-06-15
ZA928105B (en) 1993-08-25
DE69218544T2 (de) 1997-11-13
JPH05238934A (ja) 1993-09-17
DK0538897T3 (da) 1997-08-25
DE69218544D1 (de) 1997-04-30
EP0538897A1 (en) 1993-04-28
AU649169B2 (en) 1994-05-12
US5278164A (en) 1994-01-11
PH30028A (en) 1996-11-08
HK113897A (en) 1997-08-29

Similar Documents

Publication Publication Date Title
SE8703625D0 (sv) New medical use
HUT59313A (en) Process for producing pharmaceutical composition comprising flupirtin as active ingredient and suitable for combatting muscular tensions
EP0363415A4 (en) Compounds for the treatment of alzheimer's disease
HK1006421A1 (en) Levobupivacaine useful for managing chronic pain
EP0378692A4 (en) Catheter for medical treatment
GR3019050T3 (en) Dental adhesive
HU9301253D0 (en) Medical preparative applicable for treatment of enlarged time of coagulation
DK399288A (da) Dobbeltstrenget rna-korrektion af abnormiteter i cirkulerende immunkomplekser og monocytfunktion
PH25503A (en) Method of medical treatment
DK0629400T3 (da) Idebenon-holdige præparater til behandling af Alzheimer's syge
ZA981779B (en) The use of levobupivacaine in facial surgery
EP0448004A3 (en) Catheter for medical treatment
TW217382B (sh)
SE9101341D0 (sv) New medicinal use
IL98200A0 (en) Pharmaceutical composition containing a derivative of substituted-l-valyl-l-prolinamide
ZA945431B (en) Use of benzydamine in the treatment of pathological conditions caused by TNF
EP0312132A3 (en) Veterinary and human medical remedy having an antiviral and antitumorous activity, containing 2,6-diamino-3-phenyl-azo-pyridine
HU9200147D0 (en) Medical preparations with human interleukin-2 content
UA28288A (uk) Спосіб лікування шизофренії
ZA921101B (en) Use of tetra: Hydro-thieno-pyrido-indole derivatives for the prepartion of a medicine for the treatment of skin disorders.
UA10000A (uk) Спосіб лікування гострої недостатності тканинного дихання
ITMI910442V0 (it) Struttura di zoccolo ortopedico, o simile, in particolare per la prevenzione o la cura del valgismo dell'alluce
YU15301A (sh) PRIMENA R (+)- alfa-(2,3-DIMETOKSIFENIL)-1-[2-(4-FLUOROFENIL) ETIL] -4-PIPERIDINMETANOLA ZA LECENJE POREMEĆAJA SPAVANJA
ES1019006Y (es) Jeringa de anestesia dental desechable.
DK86093D0 (da) Praeparat til medikamentel behandling for tandlaegebrug mod lidelserne tandkoedsbetaendelse og tandnervebetaendelse